Why HRT ordering is a formulary-breadth and cadence problem
Compounded hormone therapy is rarely a single SKU. A program can combine estradiol, progesterone, testosterone, and combination preparations in multiple formats, and patients stay on a regimen for months. That makes ordering about formulary breadth and cadence: can you reorder a varied regimen predictably, route each preparation to the right 503A partner, and keep per-vial cost stable across cycles. The Rx Spot lists hormones among its featured protocol categories and routes compounded orders to 503A and 503B partners, but the platform's primary model is a patient-facing white-label storefront where operators set tiered retail pricing. The specific HRT preparations, formats, and B2B per-vial cost are not published publicly and arrive after a sales conversation.
For clinics that already prescribe and want to batch in-office HRT refills — building a recurring run across multiple preparations, routing each to the right compounder, and seeing cost before payment — confirm how The Rx Spot's ops-portal mode serves that workflow. The storefront model, where patients order directly through a branded DTC site, is designed for a different operator context.